Optovue has received FDA 510(k) clearance for an updated version of its proprietary spectral-domain optical coherence tomography system (RTVue XR FD-OCT system).
Fremont, CA-Optovue has received FDA 510(k) clearance for an updated version of its proprietary spectral-domain optical coherence tomography system (RTVue XR FD-OCT system).
The new version increases the number of A-scans per second to 70,000. It is scheduled to be available in the third quarter of this year.
“This FDA clearance affirms [the proprietary OCT system’s] position as the market leader, now with the fastest scan speed of any FDA-cleared device available,” said Jay Wei, Optovue chief executive officer. “We continue to leverage our experience in OCT product development and Fourier-domain technology to serve the needs of physicians and patients.”
For more articles in this issue of Ophthalmology Times eReport, click here.
